Article

A Modified Novel Validated High-Throughput Hemagglutinin Inhibition Assay Using Recombinant Virus-Like Particles and Human Red Blood Cells for the Objective Evaluation of Recombinant Hemagglutinin Nanoparticle Seasonal Influenza Vaccine

2024-10-11

Abstract excerpt

Currently available seasonal influenza vaccines confer variable protection due to antigenic changes resulting from accumulation of diverse mutations. Analysis of new seasonal influenza vaccines is challenging in part due to limitations of the traditional hemagglutination inhibition (HAI) assay with A/H3N2 strains. An improved and objective novel HAI assay was developed using recombinant virus-like particles (VLPs)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f5b7098a-11b7-514b-97b2-7992cdb23700
DOI: 10.20944/preprints202410.0884.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Modified Novel Validated High-Throughput Hemagglutinin Inhibition Assay Using Recombinant Virus-Like Particles and Human Red Blood Cells for the Objective Evaluation of Recombinant Hemagglutinin Nanoparticle Seasonal Influenza VaccineDOI 10.20944/preprints202410.0884.v1Read

Serologic assays for influenza surveillance, diagnosis and vaccine evaluation.Semantic proximity Read

H5N1 Virus-Like Particle Vaccine Elicits Cross-Reactive Neutralizing Antibodies That Preferentially Bind to the Oligomeric Form of Influenza Virus Hemagglutinin in HumansSemantic proximity Read

Hemagglutination Inhibition (HAI) antibody landscapes after vaccination with H7Nx virus like particles.Semantic proximity Read

Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strainSemantic proximity Read

Neuraminidase-Based Cross-Protective Immunity against H5N1 Influenza Viruses in HumansSemantic proximity Read

Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strainSemantic proximity Read

Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approachesSemantic proximity Read

Development of an mRNA vaccine against a panel of heterologous H1N1 seasonal influenza viruses using a consensus hemagglutinin sequenceSemantic proximity Read

A Multi-Center, Controlled Human Infection Study of Influenza A (H1N1)pdm09 in Healthy AdultsSemantic proximity Read

A miniaturized assay for influenza neuraminidase‐inhibiting antibodies utilizing reverse genetics‐derived antigensSemantic proximity Read

A Multiplex Label-Free Approach to Avian Influenza Surveillance and SerologySemantic proximity Read

Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performanceSemantic proximity Read